Does inflammation increase hepcidin to trap iron and lower transferrin saturation despite high ferritin?

The claim that inflammation increases hepcidin, leading to ferroportin degradation and iron sequestration, is a well-established pathophysiological model. This mechanism explains why patients with chronic inflammatory conditions often exhibit low transferrin saturation despite having elevated ferritin levels.

Clinical and physiological evidence

The diagnostic hallmark of "anemia of chronic disease" or "anemia of inflammation" is the presence of low serum iron and low transferrin saturation (TSAT < 20%) alongside normal or elevated serum ferritin (>100–300 ng/mL).

• Sequestration vs. Deficiency: Unlike absolute iron deficiency, where ferritin is low (<30 ng/mL), inflammatory states trap iron within the body's recycling centers.
• Clinical Indicators: Major clinical guidelines (including those from KDIGO for kidney disease and ESC for heart failure) utilize this specific biomarker pattern—low TSAT with high ferritin—to identify "functional iron deficiency," where iron is present in the body but unavailable for red blood cell production.
• Acute Phase Response: Ferritin itself acts as an acute-phase reactant; its levels rise directly in response to inflammatory cytokines, further decoupling it from actual iron availability during illness.

Mechanistic explanations

The biological pathway linking inflammation to altered iron markers is driven by the HAMP gene, which encodes the hormone hepcidin.

• Cytokine Signaling: During inflammation, interleukin-6 (IL-6) activates the JAK/STAT3 signaling pathway in the liver. This directly upregulates the transcription of hepcidin.
• The Hepcidin-Ferroportin Axis: Hepcidin serves as the "master regulator" by binding to ferroportin, the only protein capable of exporting iron out of cells.
• Degradation and Trapping: Upon binding, hepcidin induces the internalization and lysosomal degradation of ferroportin. Without this exit channel, iron remains trapped inside splenic and hepatic macrophages (which recycle iron from old red blood cells) and duodenal enterocytes (which absorb dietary iron).
• Systemic Result: This cellular "locking" of iron reduces the amount of iron entering the plasma. Consequently, transferrin (the transport protein) becomes less saturated, even as intracellular storage (reflected by ferritin) increases.

Bottom line

The claim is fully supported by scientific evidence. Inflammation triggers a hepcidin-mediated "shunting" of iron into storage, resulting in the characteristic laboratory finding of low transferrin saturation despite elevated ferritin. This process represents a biological defense mechanism intended to withhold iron from circulating pathogens.